You are here: Industry Insights > Takeda

News List

Takeda announce new UK MD, ahead of possible Shire transformation pharmafile
April 28, 2018
Jon Neal will take on the role after being promoted internally from his former position as Business Unit Director for Takeda’s UK Oncology unit. Should the deal for Shire go ahead, as it looks almost certain that it will, then Neal is going to have a lot
Takeda bids on Shire for $64-billion biospectrumasia
April 28, 2018
The companies also received an extension from UK regulators until May 8 for Takeda to make a firm offer
Shire recommends Takeda’s £46bn bid pharmaphorum
April 26, 2018
It looks like the biggest pharma merger of the year so far is on, after Shire recommended shareholders accept a bid from Takeda worth around £46 billion.
Takeda reaches preliminary agreement to acquire Shire firstwordpharma
April 25, 2018
Shire said Wednesday that it would "be willing to recommend" that shareholders accept Takeda's revised offer, which is valued at 46 billion pounds ($65 billion).
Takeda eyes Shire, will it be 2018’s biggest deal? biospectrumasia
April 25, 2018
Japan’s Takeda in negotiations to acquire Irish drugmaker Shire, a global rare disease drug giant. A successful acquisition will generate a global pharmaceutical powerhouse worth over $80bn with $30 bn in annual sales.
Takeda woos Shire shareholders with increased bid pharmaphorum
April 24, 2018
Takeda has sweetened its offer for Shire, increasing its bid slightly and improving its terms to win over the UK-listed firm’s shareholders after a string of rejections.
Takeda Comes Back to the Table, Shire Acquisition Bid Continues to Twist and Turn biospace
April 23, 2018
Takeda Pharmaceutical has come back to the bargaining table with a juicier bid for Shire
Shire’s $2.4bn oncology sell-off seen as Takeda spoiler pharmaphorum
April 17, 2018
Shire is to sell its oncology business to France’s Servier for $2.4 billion, in a move seen as a deterrent to a takeover by Takeda.
Takeda looks for loans to fund $40bn Shire takeover pharmaphorum
April 13, 2018
Takeda appears to be preparing its bid for rare diseases pharma Shire, reportedly sounding out major creditors for loans to finance the deal of up to $40 billion.
Takeda CEO Discusses Potential Shire Deal in Closed-Door Meeting With Analysts biospace
April 08, 2018
Shares of Shire Plc spiked overnight after increased rumors that Japanese pharma giant Takeda could be closer to making a deal to acquire the rare disease company.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page